Detalhe da pesquisa
1.
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Blood
; 141(25): 3031-3038, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084383
2.
A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism.
Blood
; 141(25): 3109-3121, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947859
3.
Silent cerebral infarction during immune TTP remission: prevalence, predictors, and impact on cognition.
Blood
; 142(4): 325-335, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216688
4.
Genetic justification of COVID-19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm.
J Cell Mol Med
; 28(4): e18105, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339761
5.
Pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
Blood
; 139(23): 3361-3365, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349667
6.
How I treat paroxysmal nocturnal hemoglobinuria.
Blood
; 137(10): 1304-1309, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512400
7.
Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab.
Blood
; 138(20): 1928-1938, 2021 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314483
8.
Biosimilars in rare diseases: a focus on paroxysmal nocturnal hemoglobinuria.
Haematologica
; 108(5): 1232-1243, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519328
9.
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis.
Acta Haematol
; 146(1): 1-13, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108594
10.
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.
Blood
; 136(18): 2080-2089, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877502
11.
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS.
Blood
; 135(4): 239-251, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812994
12.
Complement dysregulation is associated with severe COVID-19 illness.
Haematologica
; 107(5): 1095-1105, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289657
13.
Maternal and fetal outcomes of pregnancy occurring after a diagnosis of immune-mediated thrombotic thrombocytopenic purpura.
Ann Hematol
; 101(10): 2159-2167, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932324
14.
Genetic justification of severe COVID-19 using a rigorous algorithm.
Clin Immunol
; 226: 108726, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845193
15.
Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.
Blood
; 134(13): 1037-1045, 2019 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431443
16.
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria
Haematologica
; 106(12): 3188-3197, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121236
17.
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria.
Haematologica
; 106(1): 230-237, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949012
18.
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
Transfusion
; 61(1): 266-273, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179792
19.
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
Eur J Haematol
; 106(3): 389-397, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301613
20.
Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura.
Am J Hematol
; 96(12): 1587-1594, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460124